Biden To Invoke Defense Production Act After Trump Wouldn’t


One in every thousand Americans has caught the coronavirus. That is a startling statistic. Prior to the upcoming holiday bump, 19 million people have caught this terrible disease, and 334,230 lie in their cold, dark graves. Yet, Donald Trump plays his golf as America burns up with fever. But there is good news on the war front.

President-elect Joe Biden has decided to step into the COVID-19 leadership role that Donald has decided to vacate. Biden’s plan includes invoking the Defense Production Act as soon as he takes office next month. The purpose of that act is to kick-start COVID-19 vaccine production.

The Defense Product Act is a wartime production law, and this is an invisible attack on America. The act lets Biden make companies place this vaccine manufacturing in the forefront of all other production for “national security purposes,” according to CNBC. In addition:

‘It could help U.S. secure components and specialized products that manufacturers need to produce the vaccines.’

A member of Biden’s COVID-19 advisory board, Dr. Celine Grounder said:

‘You will see him invoking the Defense Production Act. The idea there is to make sure the personal protective equipment, the test capacity and the raw materials for the vaccines are produced in adequate supply.’

Trump’s coronavirus vaccine czar Moncef Slaoui was the previous head of GlaxoSmithKline’s vaccines department for 30 years. He retired in 2017 before the president called upon him to become his vaccine czar. Slaoui spoke at a Wednesday press briefing where he said things were moving more slowly than he had anticipated:

‘We’re here to help the states to accelerate appropriately. [The goal of 20 million vaccinations is] unlikely to be met.’

Pfizer produced the original 100 million doses for our country. In addition, our government negotiated for another 100 million doses by July 2021:

‘The U.S. government agreed to invoke the Defense Production Act to “help Pfizer get better access to around nine specialized products it needs to make the vaccine.”’

Pfizer started asking the administration for help last September. It needed some supplies for production that it could not readily acquire. The major pharmaceutical company told The New York Times that it was disappointed by Trump’s lack of interest.

As part of Operation Warp Speed, Trump’s administration invested in six companies’ efforts to produce a vaccine. However, just two have received the Food and Drug Administration (FDA) approval, Pfizer and Moderna.

Thus far, fewer than two million Americans have been vaccinated, according to the Centers for Disease Control and Prevention (CDC). That was below Trump’s original goal to vaccinate 20 million people by year’s end. Assistant Secretary of Health Admiral Brett Giroir indicated that the CDC data always lags between the state’s data.

The Mueller Report Adventures: In Bite-Sizes on this Facebook page. These quick, two-minute reads interpret the report in normal English for busy people. Mueller Bite-Sizes uncovers what is essentially a compelling spy mystery. Interestingly enough, Mueller Bite-Sizes can be read in any order.